Vitamin B Complex
drugOn this page
Summary
Vitamin B Complex (CHEMBL2108015) is a phase-3 clinical-stage unknown; indicated across 1 condition including hydatidiform mole.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 1 condition
- Clinical trials: 10
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108015 |
| Name | Vitamin B Complex |
| Type | Unknown |
| Max phase | 3 |
Also known as: Vitamin b complex, VITAMIN B COMPLEX
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
1 indication (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| hydatidiform mole | 3 | MONDO:0006248 | EFO:1000298 |
Clinical trials
Total trials: 10.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 4 |
| PHASE4 | 3 |
| PHASE3 | 2 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT07296354 | PHASE4 | NOT_YET_RECRUITING | Evaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic Polyneuropathy |
| NCT07592897 | PHASE4 | NOT_YET_RECRUITING | Vitamin B Complex for Inferior Alveolar Nerve Paresthesia Recovery |
| NCT04893733 | PHASE4 | COMPLETED | Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI |
| NCT01283646 | PHASE3 | COMPLETED | Efficacy and Tolerability of Apevitin BC Comparing to Vitamin Complex in Stimulating the Appetite |
| NCT01984099 | PHASE3 | COMPLETED | RCT on the Efficacy of Methotrexate for the Prevention of GTD |
| NCT03564678 | PHASE2 | TERMINATED | Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia |
| NCT06857734 | Not specified | NOT_YET_RECRUITING | Analgesic and Anti-inflamatory Effect of Vit. B |
| NCT07312123 | Not specified | RECRUITING | A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome |
| NCT02537392 | Not specified | COMPLETED | Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease |
| NCT07191587 | Not specified | COMPLETED | A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response. |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: hydatidiform mole